Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8YEV

Dual-specificity tyrosine phosphorylation-regulated kinase 1A in complex with coumestrol

8YEV の概要
エントリーDOI10.2210/pdb8yev/pdb
分子名称Dual specificity tyrosine-phosphorylation-regulated kinase 1A, Coumestrol (3 entities in total)
機能のキーワードinhibitor, complex, kinase, hydrolase
由来する生物種Homo sapiens
タンパク質・核酸の鎖数2
化学式量合計84587.40
構造登録者
Lee, C.C.,Hsu, K.C. (登録日: 2024-02-23, 公開日: 2025-01-01)
主引用文献Peng, C.H.,Hwang, T.L.,Hung, S.C.,Tu, H.J.,Tseng, Y.T.,Lin, T.E.,Lee, C.C.,Tseng, Y.C.,Ko, C.Y.,Yen, S.C.,Hsu, K.C.,Pan, S.L.,HuangFu, W.C.
Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor.
Int.J.Biol.Macromol., 282:136860-136860, 2024
Cited by
PubMed Abstract: Alzheimer's disease (AD) is an irreversible neurodegenerative disease, with tau pathology caused by abnormally activated dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) being one of the culprits. Coumestrol, a phytoestrogen and natural antioxidant found in various plants, has been reported to alleviate AD, but the underlying mechanism remains unclear. We confirmed coumestrol as a novel DYRK1A inhibitor through enzyme-based assays, X-ray crystallography, and cell line experiments. Coumestrol exhibited minimal cytotoxicity at concentrations up to 100 μM in cell types such as N2A and SH-SY5Y and reduced DYRK1A-induced phosphorylated tau protein levels by >50 % at 60 μM. In the tau protein phosphorylation and microtubule assembly assay, coumestrol at 30 μM reduced phosphorylated tau by >50 % and restored the microtubule assembly process. Coumestrol also significantly reduced amyloid-β (Aβ)-induced oxidative stress in microglia at 1 μM. In zebrafish larvae co-overexpressing DYRK1A and tau, coumestrol mitigated neuronal damage and protected motor function at 48 h-postfertilization. Our results suggest that coumestrol has potential therapeutic effects in AD by inhibiting DYRK1A, lowering p-Tau levels, restoring microtubule assembly, and protecting microglia cells from Aβ-induced cell death, providing new insights into the development of coumestrol as a potential AD treatment.
PubMed: 39481728
DOI: 10.1016/j.ijbiomac.2024.136860
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.25152331476 Å)
構造検証レポート
Validation report summary of 8yev
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon